A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

May 10, 2018

Study Completion Date

May 18, 2018

Conditions

Healthy Subjects

Interventions

DRUG

Selexipag

Each film-coated tablet contains 200 microgram (mcg) of selexipag (oral use)

DRUG

Clopidogrel

Each film-coated tablet containing 75 mg of clopidogrel (oral use)

Trial Locations (1)

Clinical Pharmacology Unit (CPU), Merksem